Mechanisms of ring chromosome formation, ring instability and clinical consequences

Carregando...
Imagem de Miniatura
Citações na Scopus
94
Tipo de produção
article
Data de publicação
2011
Título da Revista
ISSN da Revista
Título do Volume
Editora
BIOMED CENTRAL LTD
Autores
GUILHERME, Roberta S.
MELONI, Vera F. Ayres
PELLEGRINO, Renata
TAKENO, Sylvia S.
SPINNER, Nancy B.
CONLIN, Laura K.
CHRISTOFOLINI, Denise M.
MELARAGNO, Maria I.
Citação
BMC MEDICAL GENETICS, v.12, article ID 171, 7p, 2011
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: The breakpoints and mechanisms of ring chromosome formation were studied and mapped in 14 patients. Methods: Several techniques were performed such as genome-wide array, MLPA (Multiplex Ligation-Dependent Probe Amplification) and FISH (Fluorescent in situ Hybridization). Results: The ring chromosomes of patients I to XIV were determined to be, respectively: r(3)(p26.1q29), r(4)(p16.3q35.2), r(10)(p15.3q26.2), r(10)(p15.3q26.13), r(13)(p13q31.1), r(13)(p13q34), r(14)(p13q32.33), r(15)(p13q26.2), r(18)(p11.32q22.2), r (18)(p11.32q21.33), r(18)(p11.21q23), r(22)(p13q13.33), r(22)(p13q13.2), and r(22)(p13q13.2). These rings were found to have been formed by different mechanisms, such as: breaks in both chromosome arms followed by end-to-end reunion (patients IV, VIII, IX, XI, XIII and XIV); a break in one chromosome arm followed by fusion with the subtelomeric region of the other (patients I and II); a break in one chromosome arm followed by fusion with the opposite telomeric region (patients III and X); fusion of two subtelomeric regions (patient VII); and telomere-telomere fusion (patient XII). Thus, the r(14) and one r(22) can be considered complete rings, since there was no loss of relevant genetic material. Two patients (V and VI) with r(13) showed duplication along with terminal deletion of 13q, one of them proved to be inverted, a mechanism known as inv-dup-del. Ring instability was detected by ring loss and secondary aberrations in all but three patients, who presented stable ring chromosomes (II, XIII and XIV). Conclusions: We concluded that the clinical phenotype of patients with ring chromosomes may be related with different factors, including gene haploinsufficiency, gene duplications and ring instability. Epigenetic factors due to the circular architecture of ring chromosomes must also be considered, since even complete ring chromosomes can result in phenotypic alterations, as observed in our patients with complete r(14) and r(22).
Palavras-chave
Referências
  1. Ogata T, 2000, KIDNEY INT, V58, P2281, DOI 10.1046/j.1523-1755.2000.00412.x
  2. KOSZTOLANYI G, 1987, HUM GENET, V75, P174, DOI 10.1007/BF00591082
  3. Sodre CP, 2010, GENET MOL RES, V9, P134, DOI 10.4238/vol9-1gmr707
  4. Knijnenburg J, 2007, EUR J HUM GENET, V15, P548, DOI 10.1038/sj.ejhg.5201807
  5. Sigurdardottir S, 1999, AM J MED GENET, V87, P384, DOI 10.1002/(SICI)1096-8628(19991222)87:5<384::AID-AJMG3>3.0.CO;2-R
  6. Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547
  7. Castermans D, 2008, EUR J HUM GENET, V16, P1187, DOI 10.1038/ejhg.2008.71
  8. Conlin LK, 2011, J MED GENET, V48, P1, DOI 10.1136/jmg.2010.080382
  9. FANG YY, 1995, AM J HUM GENET, V57, P1137
  10. Frizzley JK, 1999, J MED GENET, V36, P237
  11. Glass IA, 2006, HUM GENET, V118, P611, DOI 10.1007/s00439-005-0030-z
  12. Guilherme RS, 2010, AM J MED GENET A, V152A, P2865, DOI 10.1002/ajmg.a.33689
  13. Guilherme RS, 2011, CYTOGENET GENOME RES, V134, P325, DOI 10.1159/000329478
  14. Henegariu O, 1997, AM J MED GENET, V69, P171, DOI 10.1002/(SICI)1096-8628(19970317)69:2<171::AID-AJMG11>3.0.CO;2-I
  15. Hockner M, 2008, AM J MED GENET A, V146A, P925, DOI 10.1002/ajmg.a.32251
  16. HOWARD PJ, 1988, HUM GENET, V80, P140, DOI 10.1007/BF00702856
  17. KISTENMA.ML, 1970, AM J HUM GENET, V22, P304
  18. Kosztolanyi Gyoergy, 2009, Journal of the Association of Genetic Technologists, V35, P44
  19. Le Caignec C, 2004, ANN GENET-PARIS, V47, P289, DOI 10.1016/j.anngen.2003.10.005
  20. LEDBETTER DH, 1980, CYTOGENET CELL GENET, V27, P111, DOI 10.1159/000131472
  21. MCGINNISS MJ, 1992, AM J HUM GENET, V50, P15
  22. NISS R, 1975, HUMANGENETIK, V28, P9
  23. Purandare SM, 2005, AM J MED GENET A, V138A, P229, DOI 10.1002/ajmg.a.30382
  24. Rossi E, 2008, J MED GENET, V45, P147, DOI 10.1136/jmg.2007.054007
  25. Schinzel A, 2001, CATALOGUE UNBALANCED
  26. Schlade-Bartusiak K, 2005, AM J MED GENET A, V138A, P218, DOI 10.1002/ajmg.a.30942
  27. Seghezzi L, 1999, EUR J PEDIATR, V158, P791, DOI 10.1007/s004310051206
  28. Tumer Z, 2004, AM J MED GENET A, V130A, P340, DOI 10.1002/ajmg.a.30035
  29. Vermeesch JR, 2002, CLIN GENET, V62, P415, DOI 10.1034/j.1399-0004.2002.620511.x
  30. Ville D, 2009, DEV MED CHILD NEUROL, V51, P917, DOI 10.1111/j.1469-8749.2009.03292.x
  31. Zollino M, 2009, AM J MED GENET A, V149A, P1116, DOI 10.1002/ajmg.a.32831